Home/Filings/4/0001209191-22-038436
4//SEC Filing

Deardorf Caren 4

Accession 0001209191-22-038436

CIK 0001658247other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:45 PM ET

Size

5.5 KB

Accession

0001209191-22-038436

Insider Transaction Report

Form 4
Period: 2022-06-17
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-17+4,3754,375 total
    Exercise: $18.29Exp: 2032-06-16Common Stock (4,375 underlying)
Footnotes (1)
  • [F1]The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1
  • filerCIK 0001871152

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:45 PM ET
Size
5.5 KB